What Will Happen to West Pharmaceutical Services Inc. (WST) Next? The Stock Just Increased A Lot

September 17, 2017 - By Hazel Jackson

Investors sentiment decreased to 0.96 in Q4 2016. Its down 0.05, from 1.01 in 2016Q3. It fall, as 31 investors sold West Pharmaceutical Services Inc. shares while 97 reduced holdings. 45 funds opened positions while 78 raised stakes. 66.40 million shares or 1.35% more from 65.52 million shares in 2016Q3 were reported.
Liberty Mutual Gru Asset, a Massachusetts-based fund reported 32,219 shares. Cibc World Markets Inc has invested 0% in West Pharmaceutical Services Inc. (NYSE:WST). Goldman Sachs Gru has 925,808 shares for 0.02% of their portfolio. State Of Tennessee Treasury Department holds 0.02% or 50,000 shares. Connable Office Inc has invested 0.07% of its portfolio in West Pharmaceutical Services Inc. (NYSE:WST). The California-based Wells Fargo Mn has invested 0.01% in West Pharmaceutical Services Inc. (NYSE:WST). The United Kingdom-based Ahl Ptnrs Ltd Liability Partnership has invested 0.01% in West Pharmaceutical Services Inc. (NYSE:WST). Menta Cap Ltd Liability Corp owns 5,400 shares. Silvercrest Asset Grp Inc Ltd Liability reported 0.01% in West Pharmaceutical Services Inc. (NYSE:WST). Us Savings Bank De has 0% invested in West Pharmaceutical Services Inc. (NYSE:WST) for 2,917 shares. Sg Americas Secs Limited Com has invested 0% in West Pharmaceutical Services Inc. (NYSE:WST). Price T Rowe Assoc Incorporated Md accumulated 9.81 million shares or 0.17% of the stock. Janney Montgomery Scott Limited Liability has invested 0% of its portfolio in West Pharmaceutical Services Inc. (NYSE:WST). Guggenheim Capital Ltd stated it has 11,042 shares or 0% of all its holdings. Nj State Employees Deferred Compensation Plan has invested 0.51% in West Pharmaceutical Services Inc. (NYSE:WST).

Since May 2, 2017, it had 0 insider purchases, and 2 sales for $5.63 million activity. Shares for $384,816 were sold by Malone Daniel on Tuesday, May 2.

The stock of West Pharmaceutical Services Inc. (NYSE:WST) is a huge mover today! The stock increased 4.59% or $4.21 on September 15, reaching $95.91. About 761,446 shares traded or 112.33% up from the average. West Pharmaceutical Services Inc. (NYSE:WST) has risen 33.75% since September 17, 2016 and is uptrending. It has outperformed by 17.05% the S&P500.
The move comes after 8 months positive chart setup for the $7.10B company. It was reported on Sep, 17 by Barchart.com. We have $102.62 PT which if reached, will make NYSE:WST worth $497.00M more.

Analysts await West Pharmaceutical Services Inc. (NYSE:WST) to report earnings on October, 26. They expect $0.53 EPS, 0.00 % or $0.00 from last year’s $0.53 per share. WST’s profit will be $39.23M for 45.24 P/E if the $0.53 EPS becomes a reality. After $0.51 actual EPS reported by West Pharmaceutical Services Inc. for the previous quarter, Wall Street now forecasts 3.92 % EPS growth.

West Pharmaceutical Services Inc. (NYSE:WST) Ratings Coverage

Among 3 analysts covering West Pharmaceutical Services (NYSE:WST), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. West Pharmaceutical Services had 10 analyst reports since August 4, 2015 according to SRatingsIntel. The firm earned “Hold” rating on Monday, September 11 by Jefferies. The stock of West Pharmaceutical Services Inc. (NYSE:WST) has “Outperform” rating given on Friday, October 28 by Wells Fargo. The rating was downgraded by Zacks to “Hold” on Tuesday, August 4. The stock has “Market Perform” rating by Wells Fargo on Wednesday, September 21. Jefferies maintained it with “Hold” rating and $9600 target in Thursday, July 27 report. As per Friday, September 15, the company rating was upgraded by Jefferies. The stock of West Pharmaceutical Services Inc. (NYSE:WST) has “Outperform” rating given on Tuesday, March 22 by Wells Fargo. The firm earned “Hold” rating on Tuesday, June 6 by Jefferies. The rating was maintained by Jefferies with “Hold” on Thursday, June 29. The rating was initiated by Janney Capital on Friday, January 8 with “Buy”.

More news for West Pharmaceutical Services Inc. (NYSE:WST) were recently published by: Nasdaq.com, which released: “West Pharmaceutical Services (WST) Shares Cross Above 200 DMA” on September 01, 2017. Prnewswire.com‘s article titled: “West Announces Fall Investor Conference Schedule” and published on August 25, 2017 is yet another important article.

West Pharmaceutical Services, Inc. is a maker of packaging components and delivery systems for injectable drugs and healthcare products. The company has market cap of $7.10 billion. The Company’s products include vial containment solutions, prefillable systems, self-injection platforms, cartridge systems and components, reconstitution and transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing and analytical services. It has a 40.96 P/E ratio. The Company’s divisions include Proprietary Products and Contract-Manufactured Products.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.